| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.06 | 0.2 |
| mRNA | BRD-K50799972 | CTRPv2 | pan-cancer | AAC | -0.051 | 0.2 |
| mRNA | AUY922 | GDSC1000 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | 0.043 | 0.2 |
| mRNA | cyanoquinoline 11 | CTRPv2 | pan-cancer | AAC | -0.074 | 0.2 |
| mRNA | blebbistatin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.2 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.087 | 0.2 |
| mRNA | Crizotinib | GDSC1000 | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | Bleomycin | GDSC1000 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | Nutlin-3a (-) | GDSC1000 | pan-cancer | AAC | 0.044 | 0.2 |